Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-09 @ 11:39 AM
Study NCT ID:
NCT06427005
Status:
RECRUITING
Last Update Posted:
2025-01-22
First Post:
2024-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
Sponsor:
Meng Qiu
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2023-71
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |